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Abstract
Background: The first government funded and sustainable dialysis unit was established in Ethiopia at Saint Paul’s
Hospital Millennium Medical College (SPHMMC). This has led to the development of a unique cohort of patients
about which very little is known. This study was conducted to describe the clinical profile and outcome of adult
Acute Kidney Injury (AKI) patients treated with intermittent haemodialysis at the dialysis center of SPHMMC.
Methods: A retrospective review of clinical records of cases of AKI who required haemodialysis support during the
time period from August 1, 2013 to February 1, 2015 was conducted.
Results: A total of 151 cases AKI requiring dialysis were included for the study. Overall, the patients were generally
younger with a mean age of 36.7 years and thus with few premorbid conditions. The most common causes of AKI
were hypovolemia (22.5 %), acute glomerulonephritis (AGN) (21.9 %) and pregnancy related causes (18.5 %). Nearly
a third (29.1 %) of patients succumbed to the AKI.
Conclusion: Infections, AGN, obstetric causes and nephrotoxins were the primary causes of dialysis requiring AKI.
Most of these causes can be prevented with simple interventions such as health education on oral rehydration,
quality prenatal and emergency obstetric care, appropriate management of infections and taking appropriate
precautions when prescribing potentially nephrotoxic medications.
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Background
AKI, previously known as Acute Renal Failure, is a clin-
ical syndrome characterized by an abrupt decline in
glomerular filtration rate sufficient to decrease the
elimination of nitrogenous waste products (urea and
creatinine) and other uremic toxins. According to a
standardized definition from the Acute Kidney Injury
Network proposed in 2007, AKI is a decline in kidney
function during 48 h as demonstrated by an increase in
serum creatinine of more than 0.3 mg/dl, an increase in
serum creatinine of more than 50 % or the development
of oliguria [1].
AKI is an increasingly common complication of crit-
ical illness, with some researches showing that as high as
1 in 5 adults and 1 in 3 children experiencing AKI per
hospital admission. Whether occurring in the commu-
nity or in the hospital, the clinical and public health
importance of AKI is well established due to the associ-
ation with high mortality and its separate independent
effect on the risk of death and resource use [2].
The epidemiology of AKI in developing countries is
unique in that certain causes, such as the infections,
obstetric causes and nephrotoxins, which are largely ob-
solete in developed countries remain important causes.
Regardless of cause, the management of AKI is mainly
supportive, with dialysis being indicated when medical
management fails to treat the complications. Haemodi-
alysis is the most commonly used renal replacement
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therapy in Africa. However, poverty, maladministration
of resources and lack of adequate funding for health in
nearly all African countries has massively stunted the
growth of haemodialysis as a modality of renal replace-
ment therapy.
There had not been a sustainable government run dia-
lysis service in Ethiopia until the establishment of the
Ethio-Egyptian Haemodialysis Unit in August of 2013 at
SPHMMC. This had led to the development of a unique
cohort of patients about whom little is known. The aim
of this study is to describe the clinical profile and out-
come of all adult AKI patients treated with intermittent
haemodialysis at the unit in the first 18 months since its
establishment. This study is the first of its kind to
describe the etiology and clinical profile of AKI patients
requiring dialysis in Ethiopia.
Methods
A hospital based retrospective cross-sectional study was
done at the Ethio-Egyptian Haemodialysis Unit at
SPHMMC. SPHMMC is a teaching tertiary hospital
found in the Ethiopian capital Addis Ababa and gives
care to patients from all corners of the country. The
study population were all adult AKI patients who re-
quired haemodialysis at the unit from August 1, 2013 to
February 1, 2015.
The medical record numbers of all patients dialyzed
during the study period were identified from the dialysis
unit log book and the clinical records retrieved from the
hospital record office. All patients of age 14 and above
with AKI and have been dialyzed at least once during
the study period were included. In the hospital patients
of age 14 and above are considered as “adults” and ad-
mitted to the adult patient wards. Those patients who
had dialysis for overdose of dialyzable drugs, those who
were under the age of 14 or had incomplete or missing
records were excluded.
Data on socio-demographic and premorbid condition,
clinical presentation and laboratory variables, dialysis
variables and outcome were collected using a structured
questionnaire. It was entered into and analysed using
Statistical Package for Social Sciences (SPSS) Version 20.
Results
Socio-demographics and premorbid condition
A total of 243 patients (adult and children) underwent
dialysis from August 1, 2013 to February 1, 2015. Of
these, a total of 151 adult patient records were included
in the study. The others were excluded because 10 were
paediatric patients (under the age of 14), 9 had haemodi-
alysis for overdose of dialyzable drugs and the rest were
dialyzed for CKD or their records were missing.
The mean age of patients was 36.7 ± 14.5 years, with
more than two third being in the age group between 21
to 40 years. Gender distribution was nearly equal, with
50.3 % being male. Patients came from all corners of the
country with more than a third (38.4 %) coming from
the capital Addis Ababa and two third (67.5 %) were
urban residents (Table 1). The majority (90.7 %) of
patients acquired AKI in the community.
Premorbid condition
The most common premorbid condition identified were
HIV infection (15.9 %), followed by hypertension
(14.1 %) and cerebrovascular accident (3.3 %). Four pa-
tients (2.6 %) had confirmed diabetes. Only four patients
had base line premorbid renal function test with mean
serum creatinine value of 1.01 mg/dl.
Causes and clinical presentation
The most common presenting features were oliguria
(86.1 %), followed by edema (58.9 %), encephalopathy
(49 %) and 11.3 % present with convulsion. The com-
monest causes of AKI were hypovolemia (22.5 %), either
gastrointestinal loss (in the form of diarrhoea or vomit-
ing) or blood loss, followed by AGN (21.9 %) and preg-
nancy related cause (18.5 %). Table 2 summarizes the
causes of dialysis requiring AKI in the study period.
Causes of hypovolemia, the most common cause of AKI
in this study, were severe and uncorrected gastrointes-
tinal loss (due to presumed infectious causes amongst
others) and blood loss (due to trauma and surgery.
Table 1 Socio-demographic characteristics of dialysis requiring
AKI patients, SPHMMC, Addis Ababa, May 2015
Socio-demographic variables Sub variable Frequency Percent
Gender Male 76 50.3
Female 75 49.7







Residence Urban 102 67.5
Rural 49 32.5





Dire Dawa 3 2
Ethiopian Somali 1 0.7
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Though difficult to accurately diagnose in our setup
due to lack of availability of renal biopsy, AGN (diag-
nosed through clinical means) was found to be a com-
mon cause of AKI requiring dialysis. We diagnosed
AGN clinically when there is an acute onset of oliguria
followed by body swelling, with new onset hypertension,
glomerular haematuria and some degree of proteinuria.
The pregnancy related causes include severe pre-
eclampsia/eclampsia in 20(12.5 %), puerperal sepsis in
5(3.3 %), postpartum haemorrhage in 2(1.3 %) and one
case (0.7 %) of septic abortion.
The most common nephrotoxins were the aminogly-
coside gentamycin and the antiretroviral drug Tenofovir,
followed by antineoplastic drugs and vancomycin. The
common post renal obstructive causes were stone
disease, followed by benign prostatic hyperplasia and
strictures. Other causes accounting for a minority of
cases include malignant hypertension, Tumor Lysis
Syndrome, rhabdomyolysis following electric burn injury
and interstitial nephritis.
Twenty Seven (16.9 %) of patients had AKI superim-
posed on CKD, with the most common cause of CKD
being hypertension (51.9 %). A majority of these patients
had not been diagnosed initially with CKD as they were
presenting to a health facility for the first time. Diabetes
and hypertension accounted for a combined 56 % of
causes of these background CKD and a quarter (22 %)
having no immediately identifiable cause.
Laboratory values
Nearly all of the patients had mild anaemia on admis-
sion, and had an average drop of 2 g/dl of haemoglobin
at discharge. The mean levels of creatinine at admission
and discharge were 10.18 ± 5.19 and 4.97 ± 3.54 mg/dl
respectively and for potassium the value was 5.03 ± 1.35
and 4.06 ± 1.02 mEq/L at admission and discharge
respectively. Table 3 summarizes the values for selected
laboratory parameters.
Dialysis and outcome variables
The average number of dialysis sessions was 4.8, with a
maximum of 31 and a minimum of 1. The most com-
mon indication for dialysis was refractory fluid overload
(89.4 %), followed by uremic signs and symptoms
(61.1 %) (Table 4).
Average duration of hospital stay was 20.7 days, with
range of 1–92 days. Of the 151 patients, 80 (53 %) were
discharged improved, and 44 (29.1 %) died, with the
remaining absconding (10.6 %) or progressing to end
stage renal disease (7.3 %). Hypovolemia, AGN and sep-
sis are the causes of AKI which accounted for more than
half (54.5 %) of deaths (Table 2). The most common
cause of death was sudden cardiac arrest and the causes
of death for the others are shown in Table 5.
Discussion
As the first study on dialysis requiring AKI, the study has
shade some light on the epidemiology, causes and progno-
sis for these patients in the Ethiopian context. The rela-
tively young age of patients is consistent with results from
other parts of Africa and can be explained by the predom-
inantly young overall population demographics of most
Table 2 Common Causes of dialysis requiring AKI, SPHMMC,
Addis Ababa, May 2015
Common cause of
dialysis requiring AKI
Number (%) Number of deaths from a
specific cause of AKI (%)
Hypovolemia 34(22.5) 10(22.7)
Pregnancy Related Cause 28(18.5) 3(6.8)




Nephrotoxic Drugs 8(5.3) 6(13.6)
Others 12(7.9) 6(13.6)
Total 151(100 %) 44(100 %)
Table 3 Selected Laboratory Values dialysis requiring AKI
patients, SPHMMC, Addis Ababa, May 2015
Lab values Point in time Mean ± standard deviation
Urea Admission 218.34 ± 134.53 mg/dl
Discharge 104.25 ± 87.72 mg/dl
Creatinine Admission 10.18 ± 5.19 mg/dl
Discharge 4.97 ± 3.54 mg/dl
Serum K Admission 5.03 ± 1.35 mEq/L
Discharge 4.06 ± 1.02 mEq/L
WBC count Admission 12.56 ± 8.03 × 103/ml
Discharge 9.03 ± 5.35 × 103/ml
Haemoglobin Admission 10.06 ± 2.94gm/dl
Discharge 8.85 ± 2.92 gm/dl
Platelet count Admission 254.1 ± 180.57 × 103/ml
Discharge 278.82 ± 179.06 × 103/ml
Table 4 Indication for dialysis of AKI patients, SPHMMC, Addis
Ababa, May 2015
Dialysis indicationa Frequency (Percent)
Yes No
Refractory Fluid Overload 135 (89.4 %) 16 (10.6 %)
Uremic signs and symptoms 93 (61.6 %) 58 (38.4 %)
Hyperkalemia 44 (29.1 %) 107 (70.9 %)
Metabolic Acidosis 14 (9.3 %) 137 (90.7 %)
aSum is more than 100 % as most patients had more than one indication
for dialysis
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sub-Saharan countries from which similar researches were
done [3, 4].
The prevalence of premorbid conditions is relatively
low which might be explained by the relatively younger
and thus healthier condition of the patients. HIV infec-
tion is the most common premorbid condition identi-
fied. This is a reflection of the overall prevalence of HIV
infection in the country which is 1.5 % of the 15–49 age
group according to the 2011 Ethiopian demographic
health survey [5]. Previous studies has shown that
patients with HIV infection are more likely to develop
kidney disease because of the HIV virus itself, the oppor-
tunistic infections arising from the immune-deficient
state and the drugs that these patients take [6]. In line
with results from multiple studies, diabetes and hyper-
tension accounted for a the majority of cases of back-
ground CKDs [4].
The most common presenting features were oliguria
followed by edema and encephalopathy and this is simi-
lar to findings from Emen-Chioma from Nigeria and
Bagshaw from Calgary, Alberta Canada [3, 7].
In contrast to developed countries infections, obstetric
complications and nephrotoxins are the major cause of
AKI in the tropics. This is also reflected in this study,
where the top 5 causes fall into one of these 3 categories;
hypovolemia, either gastrointestinal loss (in the form of
diarrhoea or vomiting) or blood loss, followed by AGN
and pregnancy related causes. Similar results were found
in studies done in other parts of Africa, where hypovol-
emia (or one of its causes) ranks in the top 3 causes of
AKI [4, 8–11]. Though initially correctable with volume
correction, as cellular dysfunction continues, renal tubu-
lar cells sustain ischemic injury which may persist after
correction of the initial hypoperfusion [3].
AGN was found to be a common cause of AKI requir-
ing dialysis and this corresponds to previous reports that
AGN appears to be higher in developing countries, as
evidenced by the high burden in countries like Turkey
and Northern Africa [12].
All the pregnancy related causes which includes severe
preeclampsia/eclampsia, puerperal sepsis in, postpartum
haemorrhage and septic abortion are preventable. This
indicates the need for increasing access to appropriate
and good quality prenatal and emergency obstetric care
services.
The average number of dialysis sessions was 4.8, which
is nearly twice that of what was given at a center in
Nigeria [3]. However, in the Nigerian study they have
stated that the reason for the relatively smaller number
of dialysis sessions is financial, as most of their patients
could not afford to keep paying the cost and abscond
after a couple of cycles.
The most common indication for dialysis was refrac-
tory fluid overload and uremic signs and symptoms.
These results are in contrast to those from an ICU cen-
ter in Morocco and that of three health boards in
Scotland, which has found the most common indications
to be refractory hyperkalemia, followed by metabolic
acidosis [8, 9]. One possible explanation may be the dif-
ficulty in accurately diagnosing metabolic acidosis due to
lack of blood gas analysis in the Ethiopian setup.
The mortality rate of 29.1 % in our study is much
lower than the data from a global meta-analysis of stud-
ies done across the globe which has shown a pooled
AKI-associated mortality rate 49.4 % for dialysis requir-
ing AKI [2]. However, research from other parts of the
world has shown that in AKI, a stable survival rate is
not achieved until after 30–60 days postrecovery [13].
Thus considering the fact that this study did not assess
survival post discharge, it is difficult to predict that all of
the 80 patients who were discharged improved will have
good long term prognosis. Furthermore, the fate of 10 %
of patients is unknown as they absconded and dis-
charged against medical advice.
Conclusion
Consistent with other studies from developing world,
this study has also shown that infections, AGN, obstetric
causes and nephrotoxins are the primary causes of dialy-
sis requiring AKI at Saint Paul’s hospital. Most of these
causes can be prevented with simple interventions such
as health education on oral rehydration, quality prenatal
and emergency obstetric care, appropriate management
of infections and taking appropriate precautions when
prescribing potentially nephrotoxic medications.
Future studies may also benefit by better identifying
modifiable risk factors to prevent the development of
AKI from the outset. Patients came from all corners of
the country and expansion of acute dialysis services and
subspecialty nephrology care to other parts of the coun-
try is necessary.
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Table 5 Cause of death of dialysis requiring AKI patients,
SPHMMC, Addis Ababa, May 2015
Cause of death Frequency Percent
Sudden Cardiac Death 18 42.9 %
Septic Shock 14 33.3 %
ARDS 8 19 %
Cardiogenic Shock 1 2.4 %
Others 1 2.4 %
Total 44 100 %
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